Semaglutide Subcutaneous Injection Semaglutide , sold under the brand names Ozempic, Wegovy, and Rybelsus, is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management, developed by Novo Nordisk in 2012
It has been widely studied for its role in promoting wound healing, improving skin elasticity, and reducing inflammation
It also improves blood flow
In some embodiments, the auris gel formulation contains a viscosity enhancing agent sufficient to provide a viscosity of from about 50,0000 to about 1,000,000 centipoise
It occurs when there's an imbalance between free radicals and antioxidants in the body, leading to cellular damage